期刊文献+

不同免疫抑制剂对全血细胞单核细胞趋化蛋白1分泌的影响 被引量:2

Influence of different immunosuppressants on monocyte chemoattractant protein-1 secretions in the whole blood
暂未订购
导出
摘要 背景:器官移植后的患者常规使用地塞米松、他克莫司、环孢素A和麦考酚酸等临床常用的免疫抑制剂,其作用机制各不相同。有关不同免疫抑制剂对单核细胞趋化蛋白1的作用尚未见报道。目的:观察不同免疫抑制剂对全血细胞分泌单核细胞趋化蛋白1的影响。方法:取健康志愿者全血与不同免疫抑制剂(他克莫司,环孢素A,地塞米松,麦考酚酸,每种免疫抑制剂又分为低、中、高3个质量浓度)作用6h后,用佛波酯联合离子霉素刺激6h,比较不同免疫抑制剂组及免疫抑制剂联合使用单核细胞趋化蛋白1的水平。以全血单独培养作为对照。结果与结论:麦考酚酸和他克莫司不能有效抑制单核细胞趋化蛋白1的分泌;1,10mg/L地塞米松、0.05,1.25mg/L环孢素A均能够显著抑制单核细胞趋化蛋白1的分泌。因此,地塞米松和环孢素A可能通过抑制单核细胞趋化蛋白1的水平抑制单核巨噬细胞在免疫系统中发挥作用的。联合使用5μg/L他克莫司、10mg/L麦考酚酸和1mg/L地塞米松或者联合使用0.25mg/L环孢素A、10mg/L麦考酚酸和1mg/L地塞米松都可以有效抑制单核细胞趋化蛋白1的分泌,而上述免疫抑制剂单用时,仅地塞米松能有效抑制单核细胞趋化蛋白1的分泌。 BACKGROUND:In the field of organ transplantation,patients often take immunosuppressants after organ transplantation,such as CsA,FK506,DEX and MPA.However,their mechanisms of immunosuppression are different.The effect of immunosuppressive drugs on monocyte chemoattractant protein-1(MCP-1)remains poorly understood.OBJECTIVE:To investigate the effects of different immunosuppressants on the secretions of MCP-1 in whole blood.METHODS:The whole blood of healthy volunteers was mixed with different immunosuppressants for 6 hours,such as CsA,FK506,DEX and MPA,which included low,middle and high concentrations,followed by PMA and IONO stimulation for 6 hours.MCP-1 levels in whole blood samples were compared.The whole blood cultured alone served as control.RESULTS AND CONCLUSION:MCP-1 secretion was inhibited by DEX(1,10 mg/L)and CsA(0.25,1.25 mg/L).However,FK and MPA exhibited no such effect.Therefore,DEX and CsA may inhibit the function of monocytes and macrophages in immune system by diminishing the secretion of MCP-1.The combination of FK(5 μg/L),MPA(10 mg/L)and DEX(1mg/L)or CsA(0.25 mg/L),MPA(10 mg/L)and DEX(1 mg/L)can inhibit the secretion of MCP-1,but only DEX among all the immunosuppressants mentioned above exhibited significant effect on inhibiting the secretion of MCP-1 when using alone.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第18期3314-3317,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献21

  • 1Arefieva TI,Kukhtina NB,Antonova OA,et al.MCP-1 -stimulated chemotaxis of monocytic and endothelial cells is dependent on activation of different signaling cascades.Cytokine.2005; 31(6):439-446.
  • 2Ousman SS,David S.MIP-1 alpha,MCP-1,GM-CSR and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord.J Neurosci.2001; 21(13):4649-4656.
  • 3Khan WI,Motomura Y,Wang H,et al.Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells.Am J Physiol Gastrointest Liver Physiol.2006; 291(5):G803-181.
  • 4Kim B,Sarangi PR Lee Y,et al.Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.J Leukoc Biol.2006; 80(6):1405-1415.
  • 5Kanamori H,Matsubara T,Mima A,et al.Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabeticnephropathy.Biochem Biophys Res Commun.2007; 360(4):772-777.
  • 6Giunti S,Pinach S,Amaldi L,et al.The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.Kidney Int.2006; 69(5):856-863.
  • 7Cho M,Park JS,Nam J,et al.Association of abdominal obesity with atherosclerosis in type 2 diabetes mellitus (T2DM) in Korea[J].J Korean Med Sci 2008; 23(5):781-788.
  • 8Zoja C,Liu XH,Donadelli R,et al.Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice.J Am Sec Nephrol.1997; 8(5):720-729.
  • 9Hoogeveen RC,Morrison A,BoerwinMe E,et al.Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease:Atherosclerosis Risk in Communities study.Atherosclerosis.2005; 183(2):301-307.
  • 10Ray A.Glucocorticoids.Science.1995; 270(5239):1103.

同被引文献51

  • 1李晓玉.免疫抑制剂的研究概述[J].药学服务与研究,2005,5(2):105-110. 被引量:19
  • 2石磊,蒋沁,李韶菁,张华.微生物来源的免疫抑制剂[J].国外医药(抗生素分册),2005,26(5):233-237. 被引量:8
  • 3刘日明,吴健民,高岩,潘世秀,李一荣,崔天盆.地塞米松对小鼠哮喘模型脾巨噬细胞TLR2和TLR4 mRNA表达的影响[J].中华微生物学和免疫学杂志,2005,25(9):742-746. 被引量:8
  • 4姚家琳,王会娟,徐彦,张永祥.雷帕霉素口服液的测定与稳定性研究[J].中国医药工业杂志,2006,37(11):765-767. 被引量:10
  • 5Chiba K, Adachi K. FTY720, immunosuppressant[J]. Drugs of the Fu- ture, 1997,22(1): 18-22.
  • 6Klatt J,Hartung H,Hohlfeld R. FTY720 (Fingolimod) as a new thera- peutic option for multiple sclerosis [ J ]. Der Nervenarzt, 2007,78 (10) : 1 200- 1 208.
  • 7I Enosawa S,Suzuki S,Kakefuda T,et al. Induction of selective cell death targeting on mature T- lymphocytes in rats by a novel immunosuppres- sant, FTY720 [ J ]. Immunopharmacology, 1996,34 (2 - 3 ) : 171 - 179.
  • 8Luo ZJ,Tanaka T,Kimura F,et al. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice[J]. Immunopharmacology, 1999, 41(3): 199-207.
  • 9Ando S,Amano H,Amano E,et al. FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lu- pus-prone BXSB mice[J]. Biochemical and Biophysical Research Com- munications,2010,394(3): 804 - 810.
  • 10Lopes CT,de Paula DMB,Cury PM,et al. Leishmania (Leishmania) amazonensis Infection in Mice Treated With FTY720[J]. Transplantation Proceedings,2010,42 (2): 578 - 581.

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部